TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32723928

Group type: EXPERIMENTAL
Intervention: Tai chi programs
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Dancing
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ball games
Number of subjects: 66
Study: 34223605

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy for 52 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo for 52 weeks
Number of subjects: 69
Study: 34775648

Group type: EXPERIMENTAL
Intervention: Red dichromatic imaging (RDI)
Number of subjects: 404

Group type: COMPARATOR
Intervention: White light imaging (WLI)
Number of subjects: 404
Study: 33338315

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metacognitive Therapy (MCT)
Number of subjects: 60
Study: 35510720

Group type: EXPERIMENTAL
Intervention: Preoperative chest physiotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: General care (Control)
Number of subjects: 50
Study: 32638173

Group type: EXPERIMENTAL
Intervention: Systemic enzyme therapy (SET) administered 48 hours prior to surgery
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Systemic enzyme therapy (SET) started on the day of surgery
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Systemic enzyme therapy (SET) started immediately after surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: NSAIDs (diclofenac) started 3 hours after surgery (Control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C, D)
Number of subjects: 200
Study: 36447152

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with paclitaxel/cisplatin/5‐fluorouracil (TPF) followed by concurrent chemoradiotherapy (CCRT)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 142
Study: 34193637

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham ESWT (Control)
Number of subjects: 60
Study: 36209355

Group type: EXPERIMENTAL
Intervention: Electrical vestibular nerve stimulation for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 30
Study: 34765451

Group type: COMPARATOR
Intervention: tamsulosin
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: tamsulosin plus tadalafil
Number of subjects: 140
Study: 32702334

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 6 months
Number of subjects: 1280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1280
Study: 35193168

Group type: EXPERIMENTAL
Intervention: Placebo effects with clotting factors; effect appears modest at best.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusions; hints that placebo effects might operate.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nocebo effects with transfusions; very little published information available.
Number of subjects: 0
Study: 32843265

Group type: EXPERIMENTAL
Intervention: Smartphone application education (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional clinical education (n = 30)
Number of subjects: 60
Study: 36422232

Group type: EXPERIMENTAL
Intervention: DNN model 1 using CRP and ESR
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: DNN model 2 using ESR and SUVmax
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: DNN model 3 using CRP and SUVmax
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: DNN model 4 using ESR, CRP, and SUVmax
Number of subjects: 74
Study: 34514635

Group type: EXPERIMENTAL
Intervention: First line treatment according to national guidelines
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: National registries data
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Subgroups of patients with comorbidity and high-risk MM
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: New and better treatments introduced
Number of subjects: 10000
Study: 33001536

Group type: EXPERIMENTAL
Intervention: Closed-loop Diabeloop for highly unstable diabetes (DBLHU)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Open-loop predictive low glucose suspend (PLGS)
Number of subjects: 7
Study: 35136596

Group type: EXPERIMENTAL
Intervention: Point-of-care CD4 testing
Number of subjects: 603

Group type: COMPARATOR
Intervention: Standard-of-care central laboratory CD4 testing
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Point-of-care CD4 testing (advanced HIV disease, CD4 < 200 cells/mm3)
Number of subjects: 603

Group type: COMPARATOR
Intervention: Standard-of-care central laboratory CD4 testing (advanced HIV disease, CD4 < 200 cells/mm3)
Number of subjects: 603
Study: 32100108

Group type: EXPERIMENTAL
Intervention: Acetabular Defect Classification (ADC) grading
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Acetabular Defect Classification (ADC) grading by 5 observers
Number of subjects: 287
Study: 34712863

Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg daily for 42 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 42 days)
Number of subjects: 72
Study: 32559401

Group type: EXPERIMENTAL
Intervention: Blood product transfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crystalloid infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma and albumin
Number of subjects: 0
Study: 35543302

Group type: EXPERIMENTAL
Intervention: Isolite system (IS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rubber dam isolation (RDI)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cotton roll isolation (CRI)
Number of subjects: 48
Study: 33624688

Group type: EXPERIMENTAL
Intervention: NaOCl 2ºC
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: NaOCl 45ºC
Number of subjects: 45

Group type: COMPARATOR
Intervention: NaOCl 2ºC, NaOCl 25ºC, NaOCl 45ºC
Number of subjects: 45
Study: 32100960

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP)
Number of subjects: 1935

Group type: EXPERIMENTAL
Intervention: CZP concentrations ≥ 28.0 μg/ml at week 12
Number of subjects: 1935

Group type: EXPERIMENTAL
Intervention: CZP concentrations ≥ 17.6 μg/ml at week 24
Number of subjects: 1935
Study: 35237867

Group type: EXPERIMENTAL
Intervention: EIMD in Hot
Number of subjects: 10

Group type: COMPARATOR
Intervention: EIMD in Temp
Number of subjects: 10
Study: 34606322

Group type: EXPERIMENTAL
Intervention: Multimodal screening for ovarian cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: US screening for ovarian cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32167550

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided glossopharyngeal nerve block (UGPNB) with 1.5 mL of 0.5% ropivacaine and 20 mg of methylprednisolone
Number of subjects: 51

Group type: COMPARATOR
Intervention: Landmark glossopharyngeal nerve block (GPNB)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided glossopharyngeal nerve block (UGPNB)
Number of subjects: 51
Study: 36091794

Group type: EXPERIMENTAL
Intervention: 2 g LSZ capsules three times a day for 90 days
Number of subjects: 1376

Group type: COMPARATOR
Intervention: Placebo LSZ capsules for 90 days
Number of subjects: 1376
Study: 33405368

Group type: EXPERIMENTAL
Intervention: Lipid‐based peanut paste
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vanilla biscuit
Number of subjects: 80
Study: 34038300

Group type: EXPERIMENTAL
Intervention: WFG LASIK
Number of subjects: 87

Group type: COMPARATOR
Intervention: SMILE
Number of subjects: 87
Study: 32967406

Group type: EXPERIMENTAL
Intervention: High-voltage IAPRF
Number of subjects: 57

Group type: COMPARATOR
Intervention: Low-voltage IAPRF
Number of subjects: 57
Study: 35180283

Group type: EXPERIMENTAL
Intervention: Home-based care program (12 weeks)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard care (medication advice, rehabilitation exercise, nurse follow-up)
Number of subjects: 116
Study: 34102075

Group type: EXPERIMENTAL
Intervention: Arthroscopic stabilization
Number of subjects: 64

Group type: COMPARATOR
Intervention: Open stabilization
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Off-track shoulders (8 out of 56 with MRI studies)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: On-track shoulders (48 out of 56 with MRI studies)
Number of subjects: 64
Study: 33561862

Group type: EXPERIMENTAL
Intervention: 27-gauge vitrectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: 23-gauge vitrectomy
Number of subjects: 80
Study: 33115820

Group type: EXPERIMENTAL
Intervention: Lockdown period (20 days before and 20 days after lockdown)
Number of subjects: 130
Study: 35067660

Group type: EXPERIMENTAL
Intervention: 1-drop regimen of intracameral delivery of moxifloxacin and dexamethasone suspension and topical bromfenac for 30 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3-drop regimen of topical moxifloxacin 0.5% 4 times a day for 7 days, bromfenac 0.07% daily for 30 days, and prednisolone acetate 1% 4 times a day for 30 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 1-drop regimen
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3-drop regimen
Number of subjects: 30
Study: 34275159

Group type: EXPERIMENTAL
Intervention: Consented police disclosure (requires a report if the victim consents)
Number of subjects: 1045

Group type: COMPARATOR
Intervention: Compelled police disclosure (requires a report regardless of victim consent)
Number of subjects: 1045
Study: 32567522

Group type: EXPERIMENTAL
Intervention: Rat nerve growth factor combined with vitamin B
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 35871496

Group type: EXPERIMENTAL
Intervention: High APTT group
Number of subjects: 844

Group type: COMPARATOR
Intervention: Normal APTT group
Number of subjects: 844
Study: 34052163

Group type: EXPERIMENTAL
Intervention: Hydrospacing technique (HST)
Number of subjects: 54
Study: 35019176

Group type: EXPERIMENTAL
Intervention: P‐PRP/PAS
Number of subjects: 392

Group type: COMPARATOR
Intervention: P‐PAS
Number of subjects: 392

Group type: COMPARATOR
Intervention: P‐P
Number of subjects: 392
Study: 33611360

Group type: EXPERIMENTAL
Intervention: Hostility measured at baseline using the MAACL
Number of subjects: 2321
Study: 32701823

Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)
Number of subjects: 565

Group type: COMPARATOR
Intervention: Dolutegravir (DTG)+F/TAF
Number of subjects: 565
Study: 36106312

Group type: EXPERIMENTAL
Intervention: 10 mL of 0.3% ropivacaine (Group L)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 10 mL of 0.5% ropivacaine (Group H)
Number of subjects: 54
Study: 33421048

Group type: EXPERIMENTAL
Intervention: Cold pack applied for 10 minutes (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cold pack applied for 12 minutes (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cold pack applied for 15 minutes (Group 3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cold pack applied for 20 minutes (Group 4)
Number of subjects: 60
Study: 33338661

Group type: EXPERIMENTAL
Intervention: Aerosolized surfactant (AS)
Number of subjects: 149
Study: 32556606

Group type: EXPERIMENTAL
Intervention: Magnetic tracking and electrocardiography-guided catheter tip confirmation system (TCS)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Fluoroscopy
Number of subjects: 210
Study: 36334528

Group type: EXPERIMENTAL
Intervention: Practice change intervention
Number of subjects: 5694
Study: 34444999

Group type: EXPERIMENTAL
Intervention: Exercise Group (EG) - 150 min per week of supervised moderate aerobic exercise (60–65% of VO2peak)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group (CG) - maintained their daily routine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 24
Study: 32916792

Group type: EXPERIMENTAL
Intervention: Usual care plus supervised exercise program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 36160161

Group type: EXPERIMENTAL
Intervention: Multifrequency bioimpedance spectroscopy (BIS)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (clinical assessment plus single-frequency bioimpedance)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: BIS
Number of subjects: 34
Study: 33596494

Group type: EXPERIMENTAL
Intervention: Ayurvedic treatment regime (1 g Giloy Ghanvati, 2 g Swasari Ras, 0.5 g Ashwagandha, 0.5 g Tulsi Ghanvati, and 4 drops of Anu taila)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (identical-looking tablets and drops)
Number of subjects: 100
Study: 35881396

Group type: EXPERIMENTAL
Intervention: Sleep health literacy program (2-week classroom curriculum for children, 1-hour parent workshop, and 1-on-1 parent discussions)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Sleep health literacy program
Number of subjects: 519
Study: 33952584

Group type: EXPERIMENTAL
Intervention: Asthma patients during COVID-19 lockdown
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asthma patients
Number of subjects: 0
Study: 34695064

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) 150 mg/kg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline placebo (control)
Number of subjects: 10
Study: 32469850

Group type: EXPERIMENTAL
Intervention: Study intervention group (not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator (control group, not specified)
Number of subjects: 0
Study: 35687709

Group type: EXPERIMENTAL
Intervention: SBAR communication mode
Number of subjects: 239

Group type: COMPARATOR
Intervention: Traditional communication mode
Number of subjects: 239
Study: 32133462

Group type: EXPERIMENTAL
Intervention: Cranberry juice
Number of subjects: 15

Group type: COMPARATOR
Intervention: Apple juice
Number of subjects: 15
Study: 36308611

Group type: COMPARATOR
Intervention: Blind insertion manoeuvre
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Up-down optimized glottic exposure manoeuvre
Number of subjects: 60
Study: 33585896

Group type: EXPERIMENTAL
Intervention: Caffeine (3 × 150 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (3 × 150 mg/day)
Number of subjects: 20
Study: 36087309

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 5988
Study: 33648632

Group type: EXPERIMENTAL
Intervention: Microdosing of psychedelics for 4 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191

Group type: COMPARATOR
Intervention: Microdosing vs. Placebo
Number of subjects: 191
Study: 32069044

Group type: EXPERIMENTAL
Intervention: Fused thioacene with 8 aromatic rings
Number of subjects: 250000

Group type: EXPERIMENTAL
Intervention: Compounds with the lowest 130 reorganization energy
Number of subjects: 250000

Group type: COMPARATOR
Intervention: Dinaphthothienothiophene (DNTT)
Number of subjects: 250000
Study: 33954783

Group type: EXPERIMENTAL
Intervention: 600 IU of vitamin D3
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: 3750 IU of vitamin D3
Number of subjects: 221
Study: 32358383

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 34852695

Group type: EXPERIMENTAL
Intervention: NnEx (extract from sun dried Nelumbo nucifera leaves)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 60
Study: 33857051

Group type: EXPERIMENTAL
Intervention: Integration model intervention
Number of subjects: 72
Study: 34774538

Group type: EXPERIMENTAL
Intervention: Carboxymethylcellulose (CMC) 15 g per day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (emulsifier-free diet)
Number of subjects: 16
Study: 32925495

Group type: EXPERIMENTAL
Intervention: Low-Calorie Diet (LCD)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Low-Calorie Diet + Interval Exercise (LCD + INT)
Number of subjects: 25
Study: 35101860

Group type: EXPERIMENTAL
Intervention: CHW-led educational intervention
Number of subjects: 18554

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 18554
Study: 34537057

Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg weekly
Number of subjects: 80

Group type: COMPARATOR
Intervention: Adalimumab 40 mg every 2 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Abatacept in SE-positive patients
Number of subjects: 80

Group type: COMPARATOR
Intervention: Adalimumab to abatacept switch group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Abatacept non-switch group
Number of subjects: 80
Study: 32674351

Group type: EXPERIMENTAL
Intervention: Assisted conditioning activity (CA) with 5% of body mass external load
Number of subjects: 16

Group type: COMPARATOR
Intervention: Resisted conditioning activity (CA) with 5% of body mass external load
Number of subjects: 16
Study: 36235849

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including 23 interactive classroom workshops, 10 cross‐curricular activities, 13 homework challenges, visual exposure with educational posters, parent education via website, new dishes in school food system.
Number of subjects: 681

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 681
Study: 33653810

Group type: EXPERIMENTAL
Intervention: Higher lifetime amount of smoking
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Ever having smoked regularly
Number of subjects: 248
Study: 32107817

Group type: EXPERIMENTAL
Intervention: WhatsApp social group intervention (n = 504)
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Short messages control group (n = 504)
Number of subjects: 1008
Study: 35378224

Group type: EXPERIMENTAL
Intervention: Grey-white ratio (GWR) reported by radiologist
Number of subjects: 427

Group type: COMPARATOR
Intervention: Secondary endpoints (APACHE IV score, Cerebral Performance Categories, Glasgow Coma Scale, GWR-stratified 1-year survival, RAND-36)
Number of subjects: 427
Study: 34389567

Group type: EXPERIMENTAL
Intervention: Lekker Fit! intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 0
Study: 36053566

Group type: EXPERIMENTAL
Intervention: ProTaper Universal (PTU) rotary files
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ProTaper Next (PTN) rotary files
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ProTaper Gold (PTG) rotary files
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (not instrumented)
Number of subjects: 56
Study: 33705695

Group type: EXPERIMENTAL
Intervention: Secondary cytoreduction followed by chemotherapy (six 3-weekly cycles of intravenous paclitaxel [175 mg/m2] or docetaxel [75 mg/m2] combined with intravenous carboplatin [AUC 5 mg/mL per min])
Number of subjects: 357

Group type: COMPARATOR
Intervention: Chemotherapy alone (no surgery group)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Secondary cytoreduction followed by chemotherapy
Number of subjects: 357
Study: 33480986

Group type: EXPERIMENTAL
Intervention: Tailored multidomain intervention monitored with the My Active and Healthy Aging platform
Number of subjects: 101

Group type: COMPARATOR
Intervention: General health advice (Control)
Number of subjects: 101
Study: 33991996

Group type: EXPERIMENTAL
Intervention: Esketamine 0.25 mg/kg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups pooled together
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: High trait dissociation
Number of subjects: 61
Study: 32363775

Group type: EXPERIMENTAL
Intervention: Serious Illness Conversation Guide (SICG)
Number of subjects: 163
Study: 36318025

Group type: EXPERIMENTAL
Intervention: Amoxicillin with clavulanate for one week before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: No antibiotics (Control)
Number of subjects: 60
Study: 33394268

Group type: EXPERIMENTAL
Intervention: Telehealth
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Direct exercise supervision
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control (brief education)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Telehealth vs. Direct
Number of subjects: 264

Group type: COMPARATOR
Intervention: Telehealth vs. Control
Number of subjects: 264

Group type: COMPARATOR
Intervention: Direct vs. Control
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Direct
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control
Number of subjects: 264
Study: 33514447

Group type: EXPERIMENTAL
Intervention: Brief problem solving therapy (PST) delivered in four sessions over a maximum period of eight weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Brief problem solving therapy (PST)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Postnatal outcomes
Number of subjects: 50
Study: 32214298

Group type: EXPERIMENTAL
Intervention: Oral ketamine 10 mg/kg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nebulized ketamine 3 mg/kg
Number of subjects: 62
Study: 35506515

Group type: EXPERIMENTAL
Intervention: Early tracheostomy (n=188)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Standard tracheostomy (control group, n=194)
Number of subjects: 382
Study: 33877311

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus alisertib
Number of subjects: 174

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 174
Study: 36457091

Group type: EXPERIMENTAL
Intervention: 2% pilocarpine mouthwash
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1% pilocarpine mouthwash
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 48
Study: 33034099

Group type: EXPERIMENTAL
Intervention: Althaea officinalis 1% ointment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Hydrocortisone 1% ointment
Number of subjects: 22
Study: 35426510

Group type: COMPARATOR
Intervention: Q-NMES (Quadriceps Neuromuscular Electrical Stimulation)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: QG-NMES (Quadriceps and Gluteal Neuromuscular Electrical Stimulation)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Q-NMES at 20% of MVC
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: QG-NMES at 20% of MVC
Number of subjects: 11
Study: 34492731

Group type: EXPERIMENTAL
Intervention: Free intervention strategy for thalassemia screening and prenatal diagnosis offered to high-risk couples based on informed consent.
Number of subjects: 137222

Group type: COMPARATOR
Intervention: Control group offered routine hematology examinations and selective testing for thalassemia mutations.
Number of subjects: 137222

Group type: EXPERIMENTAL
Intervention: Intervention strategy cost-effectiveness.
Number of subjects: 137222